GO
Loading...

Insurance

More

  • Ohio Sues Marsh & McLennan, AIG, Other Insurers Tuesday, 28 Aug 2007 | 6:16 AM ET

    The state of Ohio has filed an anti-trust lawsuit accusing Marsh & McLennan, AIG and three other insurers and their subsidiaries of price fixing and other anti-competitive behavior, Attorney General Marc Dann said on Monday.

  • Neurochem And Alzheimer's: Breaking Code Not Easy Monday, 27 Aug 2007 | 2:35 PM ET

    Shares of Neurochem today are trading at a new low after the Canadian biotech announced its developmental drug for Alzheimer's didn't work well enough. It is the latest evidence that cracking the code of this complex disease is extremely challenging. We recently did a story on the drug called Alzhemed, the potential AD-drug market and other companies working on treatments/cures at a dementia conference in Washington, DC.

  • A Tale Of Two Cities: New Orleans After Katrina Monday, 27 Aug 2007 | 11:40 AM ET

    Two years after hurricanes Katrina and Rita swamped New Orleans, the recovery efforts have created a tale of two cities … and it is doubtful that the full grandeur of the old Crescent City will ever arise from either one of them.

  • Diabetes: Does Novo Nordisk Signal Big Developments? Monday, 20 Aug 2007 | 12:28 PM ET

    Novo Nordisk, the world's biggest diabetes drug company, is very lightly traded on the New York Stock Exchange, but check out the move in the stock today. Coincidentally, on the day that The New York Times runs a front-page story (with two jump pages) on how controlling diabetes is about lowering blood sugar and cholesterol levels, the Danish drugmaker is out with major data on its glucose fighting drug Liraglutide.

  • QBE Insurance Group, Australia's top insurer by premium income, reported a higher-than-expected first-half profit on U.S. acquisitions, and upgraded its insurance profit forecast.

  • Green On Green Friday, 17 Aug 2007 | 3:02 AM ET

    Two things have happened recently that made me realize we are at the "tipping point" of environmental awareness. One is that my company began implementing some green initiatives - a company whose rubbish bins were often filled with styrofoam cups and lunch boxes and where dozens of television and computer monitors used to hum ceaselessly overnight. The other is that Live Earth was a total flop audience-wise. Not because people were unaware of the need to protect the environment, but because everyone, including people like me, had already heard enough about it. Eighteen years after Time magazine put "Endangered Earth" on its cover, yeah, we do finally get it.

  • Ping An Insurance, China's second-largest life insurer, posted a 140% gain in first-half profit late on Thursday, driven by a contribution from its banking operations and strong investment returns amid a booming domestic stock market.

  • Zurich Financial First-Half Net Profit Surges Thursday, 16 Aug 2007 | 5:59 AM ET

    Net profit at insurer Zurich Financial Services surged 33% in the first half of the year, beating market expectations despite heavy flooding in the U.K., the company reported Thursday.

  • FDA: Behind the Numbers Wednesday, 15 Aug 2007 | 10:53 AM ET

    BioMedTracker, which monitors drug development for investors, ran some numbers for me. As of August 13th, how does the number of FDA-approved drugs and "approvable" drugs compare to the same period a year ago? According to the company, drug approvals are down 16% and approvable letters are up 55%. An approvable letter is what the FDA issues when it believes it might someday okay a drug, but only if a company provides additional -- often publicly unspecified -- data. So, for investors, "approvable" is a euphemism for delay.

  • Insurance Against the Credit Crunch Wednesday, 15 Aug 2007 | 10:08 AM ET

    While the rest of the market is struggling with liquidity issues, at least one sector isn't having trouble generating cash.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Pharma's Market Mail Tuesday, 14 Aug 2007 | 11:46 AM ET

    Bryan Gaffin, VP, Group Creative Director at G2 Direct & Digital writes to say that his division and not G2 Branding & Design is responsible for the new Pfizer website. They're part of the same company, WPP Group, but separate divisions. Credit where credit is due.

  • Aegon to Buy Merrill Insurance Units for $1.3 Billion Tuesday, 14 Aug 2007 | 1:29 AM ET

    Dutch insurer Aegon said has agreed to buy Merrill Lynch Life Insurance and ML Life Insurance of New York for $1.3 billion in cash to boost its sales of variable annuities and distribution in the United States.

  • Buffett Boosts Bet on Burlington Wednesday, 8 Aug 2007 | 11:43 AM ET

    Burlington Northern shares are picking up speed on Wall Street, after Warren Buffett added to his bet on the railroad. Buffett's apparent optimism on the rails gives Fast Money's Guy Adami an idea.  PLUS: Why Geico's Gecko may be going back to Massachusetts.

  • Insurance broker Marsh & McLennan said Tuesday quarterly earnings edged higher on revenue growth but missed forecasts, as operating expenses not related to compensation and benefits rose.

  • Second-quarter net profit at Swiss Re rose by 45%, in line with expectations, and the reinsurer said on Tuesday it saw a strong outlook for the rest of the year.

  • Munich Re Reports Rise in Second-Quarter Net Profit Monday, 6 Aug 2007 | 2:56 AM ET

    Germany's Munich Re on Monday reported a 2.2% increase in second-quarter net profit, beating expectations as a lower tax rate offset lower premiums, lower capital investment gains and higher claims.

  • Allianz Beats Second-Quarter Forecasts Friday, 3 Aug 2007 | 2:42 AM ET

    Allianz, Europe's biggest insurer, beat forecasts with net profit of 2.140 billion euros ($2.9 billion) in the second quarter, down 6% from a year earlier when the result was boosted by asset sales.

  • Pozen and Glaxo's "Hamster Problem" With Trexima Thursday, 2 Aug 2007 | 1:57 PM ET
    Chinese Hamster

    So, I just got off the Pozen conference call about the Trexima delay (by the way, it won't be called Trexima if/when it comes to market, as the FDA is asking Glaxo for a name change. The agency sometimes does this if, for example, it believes the name looks or sounds too much like an existing drug and could confuse pharmacists.)

  • Family & Money: Eight Ways To Build Wealth Tuesday, 31 Jul 2007 | 11:21 AM ET

    From healthcare to real estate to retirement, there are many steps you can take to spend less and save more.

  • The chief executive of Humana told CNBC that the company's recent quarterly performance was the best he has seen during his tenure and expects the company to capitalize on further growth opportunities."In my seven years as CEO this is probably the best quarter we've had," president and CEO Michael McCallister said in an interview.

Contact Insurance

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More